CLINICAL_TRIALS
trial_result
· 2016-11-15
Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [Phase 3]
Summary
A Phase 3 trial evaluating the addition of trastuzumab to standard combination chemotherapy in women with breast cancer; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2016-11-15